(Q34361488)

1 August 2017

1 reference

title

Gene therapy of glioblastomas: from suicide to homicide (English)

1 reference

1 August 2017

0 references

0 references

Tunici P

1 reference

1 August 2017

Gianni D

series ordinal

1 reference

1 August 2017

Finocchiaro G

series ordinal

1 reference

1 August 2017

publication date

1 January 2001

1 reference

Progress in Brain Research

1 August 2017

published in

1 reference

1 August 2017

volume

132

1 reference

1 August 2017

page(s)

711-719

1 reference

Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene Therapies

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Intracerebral delayed hypersensitivity reactions in glioblastoma multiforme patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Thymidine kinase-mediated killing of rat brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Gene therapy of experimental brain tumors using neural progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Transfection of a vector expressing wild-type p53 into cells of two human glioma cell lines enhances radiation toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Adenovirus-mediated p53 gene therapy for human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Prevention of glioma induction in rats by simultaneous intracerebral inoculation of avian sarcoma virus plus bacillus calmette-guerin cell-wall preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Improvement of transduction efficiency of recombinant adeno-associated virus vector by entrapment in multilamellar liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Adeno‐associated Virus Vector Containing the Herpes Simplex Virus Thymidine Kinase Gene Causes Complete Regression of Intracerebrally Implanted Human Gliomas in Mice, in Conjunction with Ganciclovir Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Bystander Effect-Mediated Therapy of Experimental Brain Tumor by Genetically Engineered Tumor Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Regression of Experimental Brain Tumors with 6-Thioxanthine andEscherichia coli gptGene Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Human glioma immunobiology in vitro: implications for immunogene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Adenovirus-mediated gene therapy of experimental gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Variable Efficiency of the Thymidine Kinase/Ganciclovir System in Human Glioblastoma Cell Lines: Implications for Gene Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

An experimental model of retrovirus gene therapy for malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE induction.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932112-X

7 January 2021

10.1016/S0079-6123(01)32112-X

Identifiers

DOI

1 reference

1 August 2017

1 reference